Parasitological Clearance Rates and Drug Concentrations of a Fixed Dose Combination of Azithromycin-Chloroquine in Asymptomatic Pregnant Women with Plasmodium Falciparum Parasitemia: An Open-Label, Non-Comparative Study in Sub-Saharan Africa

• Kamija Phiri ,

  * E-mail: kamijaphiri@gmail.com

  Affiliation College of Medicine, University of Malawi, Blantyre, Malawi

  ⨯
• Joshua Kimani,

  Affiliation College of Health Sciences, University of Nairobi, Nairobi, Kenya

  ⨯
• George A. Mtove,

  Affiliation National Institute for Medical Research, Amani Medical Research Centre, Tanga, Tanzania

  ⨯
• Qinying Zhao,

  Affiliation Pfizer Inc., Groton, Connecticut, United States of America

  ⨯
• Ricardo Rojo,

  Affiliation Pfizer Inc., Groton, Connecticut, United States of America

  ⨯
• Jeffery Robbins,

  Affiliation Pfizer Inc., Groton, Connecticut, United States of America

  ⨯
• Stephan Duparc,

  Affiliation Medicines for Malaria Venture, Geneva, Switzerland

  ⨯
• Ayman Ayoub,

  Affiliation Pfizer Inc., Sandwich, Kent, United Kingdom

  ⨯
• Pol Vandenbroucke

  Affiliation Pfizer Inc., New York, New York, United States of America

  ⨯